drug discovery

Two well-known techniques + new application field = breakthrough of the year

This fall, Dr. Tim Grüne from the Paul Scherrer Institute (PSI) together with Crystallise! AG published the results of their joint project, presenting...

More details

Structure-based drug discovery drives the development of novel treatment options

Drug development is a long and unpredictable process that requires high levels of investment, endurance and state-of-the-art technology. Basic research...

More details More details

New collaboration on a GPCR lead discovery project

Axxam SpA and leadXpro AG announce this week a collaboration for the discovery of novel small molecule lead compounds for a newly discovered GPCR involved...

More details More details

leadXpro about possibilities of new XFEL for applied research

Biotech startup leadXpro AG, at home at PARK INNOVAARE, applies serial crystallography among many other methods for structure-based drug design. It recently...

More details

InterAx Biotech has started a new collaboration

Collaborations speed up innovation. InterAx Biotech AG, a spin-off of the Paul Scherrer Institute (PSI) and ETH Zurich, based at PARK INNOVAARE, and...

More details

State-of-the-art bioinformatics for better drug discovery

The effect a drug has on the human body depends on how well its active substance find its way to the targeted cells in the body, and on the chemical reactions...

More details

Biosensors Technology Platform for efficient lead discovery

In April 2016, the team at InterAx Biotech AG mounted the nameplate of a newly-born company on the wall of PARK INNOVAARE’s deliveryLAB, thus giving...

More details

INNOVATION in PRACTICE 2017: technologies and products in focus

Innovation cannot be planned. But it can be achieved faster and more effectively when the innovation process is being managed properly. For the second...

More details More details

leadXpro one year in operation: all goals achieved, and even more!

Today, leadXpro AG, one of PARK INNOVAARE’s residents, celebrates its first anniversary and breathtaking development as a company in its first year of...

More details More details

Villigen – Boston – Villigen: Successful Business Trip for InterAx Biotech AG

InterAx Biotech AG participated in a “business boosting” week in Boston, USA, in June, 2016. As part of venturelab’s international program, 10 high...

More details
Subscribe to drug discovery